Taketomi A, Takenaka K, Matsumata T, Shimada M, Higashi H, Shirabe K, Itasaka H, Adachi E, Maeda T, Sugimachi K
Department of Surgery II, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Hepatogastroenterology. 1997 Mar-Apr;44(14):477-83.
BACKGROUND/AIMS: We recently demonstrated that an activated inflammation in a non-tumorous portion was a significant risk factor for recurrence in patients with small hepatocellular carcinoma. The purpose of this study is to provide further proof for this mechanism by explaining the relation ship between the post-operative hepatitis state and intrahepatic recurrence.
We used an enzyme-linked immunosorbent assay to detect cICAM-1 in the serum of 18 patients with hepatocellular carcinoma before and after hepatic resection.
A complete surgical resection of the tumor masses did not result in a significant reduction of cICAM-1 levels. The levels of aminotransferase after hepatic resection in patients with an increased level of cICAM-1 in the post operative period (n = 7) were much higher than in patients with a decreased level of cICAM-1 (n = 11) (p < 0.05). The 1-, 2- and 3- year disease free survival rates in the former group were 42.9%, 14.3% and 0%, respectively, and those in the later group were 72.7%, 54.5% and 54.5%, respectively (p < 0.05).
The enhancement of inflammation in the remnant liver tissue is related to intrahepatic recurrence after hepatic resection through adhesion molecules, such as cICAM-1.
背景/目的:我们最近证实,非肿瘤部分的炎症激活是小肝细胞癌患者复发的一个重要危险因素。本研究的目的是通过解释术后肝炎状态与肝内复发之间的关系,为这一机制提供进一步的证据。
我们采用酶联免疫吸附测定法检测18例肝细胞癌患者肝切除术前、后的血清中细胞间黏附分子-1(cICAM-1)。
肿瘤块的完全手术切除并未导致cICAM-1水平显著降低。术后cICAM-1水平升高的患者(n = 7)肝切除术后的转氨酶水平远高于cICAM-1水平降低的患者(n = 11)(p < 0.05)。前一组的1年、2年和3年无病生存率分别为42.9%、14.3%和0%,后一组分别为72.7%、54.5%和54.5%(p < 0.05)。
残余肝组织炎症增强通过cICAM-1等黏附分子与肝切除术后肝内复发有关。